Prevenzione della morte improvvisa nel paziente con insufficienza cardiaca: terapia di resincronizzazione cardiaca con o senza back-up di defibrillazione

Translated title of the contribution: Prevention of sudden death in patients with heart failure: Cardiac resynchronization therapy with or without back-up defibrillation

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The prevalence and incidence of heart failure are progressively increasing in both Europe and the United States. Despite many advances in diagnosis and therapy, morbidity and mortality remain high and long-term prognosis is still poor in most heart failure patients. The use of implantable devices, cardiac resynchronization therapy and implantable cardioverter-defibrillators plays a pivotal role in the treatment of heart failure. Cardiac resynchronization therapy improves survival and reduces cardiac mortality due to either sudden or nonsudden death. In clinical practice, patients with an indication for cardiac resynchronization therapy should be carefully evaluated in view of a potential concomitant indication for defibrillator implantation. The combination of the two therapies may have maximal beneficial effects on prognosis.

Original languageItalian
JournalGiornale Italiano di Cardiologia
Volume11
Issue number10 SUPPL.1
Publication statusPublished - Oct 2010

Fingerprint

Cardiac Resynchronization Therapy
Sudden Death
Heart Failure
Cardiac Resynchronization Therapy Devices
Defibrillators
Mortality
Implantable Defibrillators
Treatment Failure
Morbidity
Survival
Incidence
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{219322b93473432cac1193e051e520de,
title = "Prevenzione della morte improvvisa nel paziente con insufficienza cardiaca: terapia di resincronizzazione cardiaca con o senza back-up di defibrillazione",
abstract = "The prevalence and incidence of heart failure are progressively increasing in both Europe and the United States. Despite many advances in diagnosis and therapy, morbidity and mortality remain high and long-term prognosis is still poor in most heart failure patients. The use of implantable devices, cardiac resynchronization therapy and implantable cardioverter-defibrillators plays a pivotal role in the treatment of heart failure. Cardiac resynchronization therapy improves survival and reduces cardiac mortality due to either sudden or nonsudden death. In clinical practice, patients with an indication for cardiac resynchronization therapy should be carefully evaluated in view of a potential concomitant indication for defibrillator implantation. The combination of the two therapies may have maximal beneficial effects on prognosis.",
keywords = "Cardiac resynchronization therapy, Heart failure, Implantable defibrillators, Sudden death",
author = "Pedretti, {Roberto F E} and Antonio Laporta and Sergio Masnaghetti and Rosa Raimondo and Mario Salerno and Francesco Santoro and Raffaella Vaninetti",
year = "2010",
month = "10",
language = "Italian",
volume = "11",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10 SUPPL.1",

}

TY - JOUR

T1 - Prevenzione della morte improvvisa nel paziente con insufficienza cardiaca

T2 - terapia di resincronizzazione cardiaca con o senza back-up di defibrillazione

AU - Pedretti, Roberto F E

AU - Laporta, Antonio

AU - Masnaghetti, Sergio

AU - Raimondo, Rosa

AU - Salerno, Mario

AU - Santoro, Francesco

AU - Vaninetti, Raffaella

PY - 2010/10

Y1 - 2010/10

N2 - The prevalence and incidence of heart failure are progressively increasing in both Europe and the United States. Despite many advances in diagnosis and therapy, morbidity and mortality remain high and long-term prognosis is still poor in most heart failure patients. The use of implantable devices, cardiac resynchronization therapy and implantable cardioverter-defibrillators plays a pivotal role in the treatment of heart failure. Cardiac resynchronization therapy improves survival and reduces cardiac mortality due to either sudden or nonsudden death. In clinical practice, patients with an indication for cardiac resynchronization therapy should be carefully evaluated in view of a potential concomitant indication for defibrillator implantation. The combination of the two therapies may have maximal beneficial effects on prognosis.

AB - The prevalence and incidence of heart failure are progressively increasing in both Europe and the United States. Despite many advances in diagnosis and therapy, morbidity and mortality remain high and long-term prognosis is still poor in most heart failure patients. The use of implantable devices, cardiac resynchronization therapy and implantable cardioverter-defibrillators plays a pivotal role in the treatment of heart failure. Cardiac resynchronization therapy improves survival and reduces cardiac mortality due to either sudden or nonsudden death. In clinical practice, patients with an indication for cardiac resynchronization therapy should be carefully evaluated in view of a potential concomitant indication for defibrillator implantation. The combination of the two therapies may have maximal beneficial effects on prognosis.

KW - Cardiac resynchronization therapy

KW - Heart failure

KW - Implantable defibrillators

KW - Sudden death

UR - http://www.scopus.com/inward/record.url?scp=79955704592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955704592&partnerID=8YFLogxK

M3 - Articolo

C2 - 21416844

AN - SCOPUS:79955704592

VL - 11

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10 SUPPL.1

ER -